RxDoctor Payments Data

Kimberly Tilton

Family · Zanesville, OHNPI 1992013858

Payments from drug & device makers

$2,430in general payments, 2019–2025

Across 35 payments — averaging $69.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1K
  • Johnson & Johnson$208
  • Sanofi-aventis U.S. LLC$169
  • Takeda Pharmaceuticals U.S.A., Inc.$140
  • Lilly USA, LLC$106
  • Amgen$99
  • plus $535 from 11 others

What the payments were for

  • Travel & lodging$79133%
  • Food & beverage$1,20950%
  • Education$43118%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,430 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$22,718
Medicare patients
197
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$39,649
XareltoRivaroxaban26$24,441
Dabigatran EtexilateDabigatran Etexilate Mesylate11$1,469
Anastrozole107$1,061
Potassium Chloride40$814
Omeprazole35$311
Ondansetron OdtOndansetron19$302
Letrozole13$285
Dexamethasone24$283
Klor-Con M20Potassium Chloride11$191
Acyclovir12$177
Prednisone35$156
Gabapentin25$122
Levothyroxine Sodium15$64
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$208$24,44126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.

Other family in Zanesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →